BHARAT PARENTERALS
|
|
BOM : 541096     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Nov 01,2024 |
Price(EOD): ₹ 1,428.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 985.46 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BHARAT PARENTERALS | 5.4% | -11.6% | 140.1% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -2.9% | 69.8% |
CIPLA | 3.7% | -5.9% | 29.5% |
DR REDDYS LABORATORIES | -4.1% | -6.6% | 18.8% |
ZYDUS LIFESCIENCES | -0.3% | -6.1% | 74.6% |
DIVIS LABORATORIES | 1.6% | 8.7% | 74% |
MANKIND PHARMA | 10.8% | 6.3% | 53.2% |
TORRENT PHARMACEUTICALS | -3.2% | -5.4% | 66.1% |
LUPIN | -0.3% | 0.7% | 93.8% |
FUNDAMENTAL ANALYSIS OF BHARAT PARENTERALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BHARAT PARENTERALS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
38.14
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 25.81 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 4.61
P/B Calculated based on Book Value of Rs 213.61 Cr
[Latest Year - Mar2024 - Standalone Results ] 3.5
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
4427% 824% 304% |
SHARE PRICE MOMENTUM OF BHARAT PARENTERALS
BHARAT PARENTERALS vs SENSEX
DEBT OF BHARAT PARENTERALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.39 0.24 0.09 0.24 |
- - 0.11 0.04 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BHARAT PARENTERALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BHARAT PARENTERALS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-29.99% -62.22% -53.05% -54.93% |
7.76% -11.98% -0.39% -1.08% |
QtrlyTrend |
-6 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
BHARAT PARENTERALS related INDICES
You may also like the below Video Courses
FAQ about BHARAT PARENTERALS
Is BHARAT PARENTERALS good for long term investment?
As on Nov 01,2024, the Fundamentals of BHARAT PARENTERALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BHARAT PARENTERALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BHARAT PARENTERALS UnderValued or OverValued?
As on Nov 01,2024, BHARAT PARENTERALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of BHARAT PARENTERALS ?
As on Nov 01,2024, the Intrinsic Value of BHARAT PARENTERALS is Rs. 154.64 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 31.55
Fair Value [Median EV / Sales Model] : Rs. 154.64
Fair Value [Median Price / Sales Model] : Rs. 353.92
Estimated Median Fair Value of BHARAT PARENTERALS : Rs. 154.64
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.